Martin & CO Inc Abbott Laboratories Transaction History

Martin & CO Inc

$394 Million
Q3 2024

A detailed history of Martin & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Martin & CO Inc holds 9,650 shares of ABT stock, worth $1.1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

9,650

Previous 9,656 0.06%

Holding current value

$1.1 Million

Previous $1 Million 9.67%

% of portfolio

0.28%

Previous 0.27%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$100.07 - $118.13 $600 - $708	-6 Reduced 0.06%	9,650 $1.1 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $1,510 - $1,686	-15 Reduced 0.16%	9,656 $1 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $19,823 - $21,893	-181 Reduced 1.84%	9,671 $1.1 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $32,648 - $39,964	-362 Reduced 3.54%	9,852 $1.08 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $3,725 - $4,470	-39 Reduced 0.38%	10,214 $989,000
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $35,776 - $39,862	-355 Reduced 3.35%	10,253 $1.12 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $12,688 - $14,935	-131 Reduced 1.22%	10,608 $1.07 Million
Q4 2022 Feb 03, 2023	BUY	$95.06 - $111.52 $27,092 - $31,783	285 Added 2.73%	10,739 $1.18 Million
Q3 2022 Oct 26, 2022	BUY	$96.76 - $112.03 $21,577 - $24,982	223 Added 2.18%	10,454 $1.01 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $16,127 - $19,492	158 Added 1.57%	10,231 $1.11 Million
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $64,649 - $78,835	-567 Reduced 5.33%	10,073 $1.19 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $4,967 - $6,082	-43 Reduced 0.4%	10,640 $1.5 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $96,244 - $106,474	825 Added 8.37%	10,683 $1.26 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $68,128 - $80,197	-644 Reduced 6.13%	9,858 $1.14 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $1.05 Million - $1.24 Million	-9,643 Reduced 47.87%	10,502 $1.26 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $1,050 - $1,144	10 Added 0.05%	20,145 $2.21 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $4,582 - $5,564	-50 Reduced 0.25%	20,135 $2.19 Million
Q2 2020 Aug 19, 2020	BUY	$76.57 - $98.0 $10,719 - $13,720	140 Added 0.7%	20,185 $1.85 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $628,639 - $919,243	-10,007 Reduced 33.3%	20,045 $1.58 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $392 - $437	5 Added 0.02%	30,052 $2.61 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $11,457 - $12,423	-140 Reduced 0.46%	30,047 $2.51 Million
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $60,490 - $70,550	-830 Reduced 2.68%	30,187 $2.54 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $30,461 - $36,827	-460 Reduced 1.46%	31,017 $2.48 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $4,917 - $5,570	75 Added 0.24%	31,477 $2.28 Million
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $23,715 - $28,610	-390 Reduced 1.23%	31,402 $2.3 Million
Q2 2018 Aug 15, 2018	BUY	$57.57 - $63.54 $54,403 - $60,045	945 Added 3.06%	31,792 $1.94 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $1.44 Million - $1.63 Million	-25,543 Reduced 45.3%	30,847 $1.85 Million
Q4 2017 Feb 15, 2018	SELL	$53.68 - $57.47 $1,073 - $1,149	-20 Reduced 0.04%	56,390 $3.22 Million
Q3 2017 Nov 15, 2017	SELL	$48.06 - $53.64 $291,964 - $325,863	-6,075 Reduced 9.72%	56,410 $3.01 Million
Q2 2017 Aug 15, 2017	BUY	N/A	62,485	62,485 $3.04 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Martin & CO Inc with notifications on news.

Account